ONYX BIOTEC LIMITED Share Price

ONYX BIOTEC LIMITED Share Price

NSE: ONYX
|
Pharmaceuticals
|
S Cap
₹ 44.65
+₹0.95 (2.17%)
1D
Last updated 12 Aug, 2026, 15:15 IST

ONYX BIOTEC LIMITED Share Price Today

As of 12 Aug 2026, ONYX BIOTEC LIMITED share price is ₹44.65. The stock opened at ₹43.70, compared to its previous close of ₹43.70. During today's trading session, ONYX BIOTEC LIMITED share price moved in the range of ₹43.70 to ₹45.15, with an average price of ₹44.42 for the day. Looking at its last 52-week, the stock has touched a low of ₹24.20 and a high of ₹51.60. On the performance front, ONYX BIOTEC LIMITED share price has increased by 25.77% over the last six months and is down 7.94% on a year-on-year basis.

₹43.70
2.17% up today
₹45.15
1D LOW
1D HIGH

ONYX BIOTEC LIMITED Returns Calculator

Circuit
L
H
₹41.55
₹45.85
52-week
L
H
₹24.20
₹51.60

About ONYX BIOTEC LIMITED

ONYX BIOTEC LIMITED Share Price
ISIN
INE0WVU01018
Sector Market Cap
₹ 79.24 Cr

Onyx Biotec Ltd. is a pharmaceutical company engaged in the manufacture, sale, and distribution of generic and proprietary pharmaceutical products. It develops, manufactures and distributes generic and branded pharmaceutical products in various forms, like water for injection (WFI), dry powder injections, and dry powder syrup. WFI is a sterile preparation of water, which is supplied only in single-dose containers, indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection. Its dry powder injections include Ceftriaxone and Sulbactam for Injection, Cefazoline Sodium for Injection, and Cefepime and Tazobactam for Injection, among others. Its dry powder syrups include Cefpodoxime Proxetil, Cefuroxime Axetil, and others. Its core business is focused on providing end-to-end product development and manufacturing solutions to its clients. Its services also include preparation and filing of regulatory dossiers in the Indian and global markets.

ONYX BIOTEC LIMITED Financial Highlights

  • Revenue: ONYX BIOTEC LIMITED reported revenue of ₹69.91 crore in FY26 vs ₹63.12 crore in FY25. It showed an increase of 10.76% on a yearly basis.
  • Operating Profit: ONYX BIOTEC LIMITED reported an operating loss of ₹0.42 crore in FY26 vs ₹6.48 crore in FY25. It showed a decrease of 106.48% on a year-on-year basis.
  • Net Profit: ONYX BIOTEC LIMITED reported a net loss of ₹0.21 crore in FY26 vs ₹4.95 crore in FY25. It showed a decrease of 104.24% on a yearly basis.
Promoters
65.10%
FII
1.07%
Other DII
2.39%
Retail and other
31.44%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Nov 20248.72%
Mar 20255.36%
Sep 20251.95%
Mar 20261.07%
Mkt Cap Cr
79.24
P/E
-364.17
P/B
1.43
ROE
-0.39%
D/E
0.27
ROCE
1.12%
Div. Yield
0.00%
EPS(TTM)
-0.12
Turnover
1.11
EV/EBITDA
0.00
Net Margin
0.00%
Op. Margin
0.00%
ROA
0.00%
Quick Ratio
0.00
Curr. Ratio
2.33
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Onyx Biotec outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Onyx Biotec appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,471.0038.425.5713.74%0.6117.33%93.240.82%0.4810.90
Divis Laboratories2,26,631.0077.4813.5215.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,85,157.0085.8822.0225.49%1.6913.85%222.760.69%0.4958.70
Cipla1,18,107.0035.193.4311.27%0.0014.95%423.360.89%0.4543.52
Zydus Lifesciences1,17,705.0025.634.3418.59%0.3117.35%237.300.09%0.3335.38
Lupin1,04,158.0018.764.6423.76%0.0424.88%659.050.79%0.57129.18
Laurus Labs1,00,498.0092.1718.9616.77%0.4016.14%97.200.11%0.6713.72
Mankind Pharma1,00,152.0048.446.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,578.0031.592.6411.07%0.1812.54%377.960.66%0.4138.68
Aurobindo Pharma95,367.6025.702.529.25%0.1911.76%391.140.24%0.3841.58

ONYX BIOTEC LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹61.95₹53.75₹39.49₹44.86
Other Income₹1.17₹0.13₹0.12₹0.12
Total Revenue₹63.12₹53.87₹39.62₹44.98
Total Expenses₹56.64₹49.38₹37.07₹41.19
Profit Before Tax₹6.48₹4.49₹2.55₹3.80
Tax₹1.52₹0.86₹0.70₹0.44
Profit After Tax₹4.95₹3.63₹1.84₹3.35
EPS - Basic₹3.31₹3.05₹1.56₹2.84
EPS - Diluted₹3.31₹3.05₹1.56₹2.84

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹6.48₹4.49₹2.55₹3.80
Income before WC changes₹11.08₹8.55₹0.36₹5.94
Change in Assets-₹12.54-₹12.98-₹0.65-₹8.78
Change in Liabilities₹2.88₹5.95₹2.24₹3.33
Change in WC-₹9.66-₹7.03₹1.60-₹5.45
Cash flow from Operations₹1.42₹1.52₹1.96₹0.49
Cash flow from Investing₹0.66-₹3.15-₹22.67-₹5.78
Cash flow from Financing₹5.07₹3.09₹16.43₹5.20
Total Cash Flow₹7.15₹1.46-₹4.29-₹0.09
Cash (Start of the year)₹1.47₹0.01₹0.01₹0.11
Cash (End of the year)₹8.61₹1.47-₹4.28₹0.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹42.06₹44.58₹44.16₹22.41
Current Assets₹49.19₹29.56₹14.56₹14.43
Total Assets₹91.25₹74.14₹58.72₹36.84
Current Liabilities₹25.73₹22.55₹20.21₹10.03
Net Current Asset₹23.46₹7.01-₹5.64₹4.40
Non-Current Liabilities₹9.90₹26.30₹20.31₹10.43
Equity Capital₹55.62₹25.29₹18.20₹16.38
Total Equity & Liabilities₹91.25₹74.14₹58.72₹36.84
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
54.39
Neutral
ATR (14)
2.12
Neutral
STOCH(9,6)
14.39
Bullish
STOCH RSI (14)
39.25
Neutral
ADX(9)
26.45
Bearish
UO(9)
55.91
Neutral
ROC(12)
17.95
Bullish
WillR(14)
-41.18
Neutral
Period
Simple value
Exponential vaue
5D
45.95
45.13
10D
45.27
44.47
20D
41.67
42.82
50D
40.37
40.22
100D
36.68
38.06
Volume trend — traded volume by day
12 Aug0L
11 Aug0L
10 Aug0L
7 Aug0L
6 Aug0L
5 Aug0L
Average0L
Compare against other stocks
ONYX BIOTEC LIMITED Share Price
ONYX BIOTEC LIMITED
Pharmaceuticals
Add Stock
Add Another

ONYX BIOTEC LIMITED Share Price FAQs